Pune, India -- (SBWIRE) -- 03/05/2019 -- North America is the largest geographic chronic total occlusion market and it is expected to be the largest revenue generator during the forecast period. North American market is driven due to the high prevalence of coronary artery disease and peripheral artery.

The major players operating in the chronic total occlusion market are ASAHI INTECC CO., LTD, SoundBite Medical Solutions, Integer Holdings Corporation, Baylis Medical Company, Inc, SPECTRANETICS, C. R. Bard, Inc., Boston Scientific Corporation, Medtronic, Terumo Corporation, Cordis, and Abbott. For instance, in August 2017, Koninklijke Philips N.V. completed the acquisition of The Spectranetics Corporation in order to accelerate its strategic expansion into cardiovascular devices.

Get Sample Copy of Research @ https://www.theinsightpartners.com/sample/TIPMD00002711/

Chronic Total Occlusion Market Insights

Technological Advancements
Advancement in the field of science has enhanced chronic total occlusion devices. Many industry players have come up with innovative types of chronic total occlusion devices in the last few years. The advancement in the chronic total occlusion devices has led to the faster and easier treatment and recovery of patients. For instance, in September 2018, SoundBite Medical Solutions Inc. (SBMS) launched the ACTIVE Trial, recently approved study by Health Canada for the demonstration of the potential of the SoundBite Active Wire to cross coronary chronic total occlusions (CTOs). Moreover, in February 2018, Asahi Intecc received the FDA approval for CTO (Chronic Total Occlusion) indication for selected products. The approval aims to provide help to the cardiologists to successfully complete complex procedures that now account for up to 70 percent of cases.

Equipment Insights
The global chronic total occlusion market by equipment was led by the guidewires segment. In 2017, the ablation devices segment held the largest market share of 41.9% of the chronic total occlusion market, by equipment. The segment is also expected to dominate the market during the year 2025 since they offer ease in various medical procedures.

Rising Prevalence of Artery Diseases
Since the last 25 years, the number of cardiovascular cases has increased in Europe and in the European Union. The addition in the cardiovascular cases is observed in most of the countries in this region. According to the European Cardiovascular Disease Statics in 2015, near about 85 million people in Europe and 49 million in EU were suffering from cardiovascular diseases. In Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries.

End User Insights
The chronic total occlusion Market by end user was segmented into hospitals, ambulatory care centers, and others. The hospitals' segment held the largest share of the market, by end user with a share of around 61.9%. The segment is also expected to dominate during the year 2025, due to rapid technological advancements and growing investments in healthcare facilities.

Strategic Insights

Acquisitions and approvals were observed as the most adopted strategy in global chronic total occlusion Market. Few of the acquisitions and approvals made by the players in the market are listed below:

2018: In April, 2018, Asahi Intecc Co., Ltd received CTO indication from US FDA for its PTCA guidewires: ASAHI Gaia series, MIRACLEBROS/ASAHI Miracle series, CONFIANZA/Conquest series, FIELDER XT, FIELDER XT-A, FIELDER XT-R, ULTIMATEbros 3 and Microcatheters: ASAHI Corsair, Corsair Pro microcatheters.

2017: In August, 2017, Koninklijke Philips N.V. acquired The Spectranetics Corporation. This acquisition will accelerate Philip's strategic expansion into therapy devices.

Get 10% Free Customization on Purchase @ https://www.theinsightpartners.com/buy/TIPMD00002711/

The report segments the global chronic total occlusion market as follows:

- Global chronic total occlusion Market – By Equipment
o Micro Catheters
o Guide Wires
o Crossing Devices
o Re-Entry Devices

- Global Chronic total occlusion Market – By End User
o Hospitals
o Ambulatory Care Centers
o Others

- Global Chronic total occlusion Market – By Geography

- North America
o U.S.
o Canada
o Mexico

- Europe
o U.K.
o Germany
o France

- Asia Pacific (APAC)
o Japan
o China
o India

- Middle East & Africa (MEA)
o South Africa
o UAE
o Saudi Arabia

- South & Central America (SCAM)
o Brazil

About The Insight Partners
The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Automotive, Electronics, and Chemical industries.